Hercules Capital, Inc. (LON:0J4M)

London flag London · Delayed Price · Currency is GBP · Price in USD
18.16
+0.17 (0.94%)
At close: Jun 26, 2025
-9.39%
Market Cap 2.29B
Revenue (ttm) 380.45M
Net Income (ttm) 170.53M
Shares Out n/a
EPS (ttm) 1.03
PE Ratio 13.42
Forward PE 9.03
Dividend 1.38 (10.50%)
Ex-Dividend Date May 13, 2025
Volume 10,408
Average Volume 2,856
Open 18.00
Previous Close 17.99
Day's Range 17.96 - 18.19
52-Week Range 15.64 - 22.19
Beta 0.86
RSI 57.34
Earnings Date Jul 31, 2025

About Hercules Capital

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management ... [Read more]

Industry Financial - Diversified
Sector Financials
Founded 2003
Employees 100
Stock Exchange London Stock Exchange
Ticker Symbol 0J4M
Full Company Profile

Financial Performance

In 2024, Hercules Capital's revenue was $493.59 million, an increase of 7.15% compared to the previous year's $460.67 million. Earnings were $260.14 million, a decrease of -22.15%.

Financial numbers in USD Financial Statements

News

Hercules Capital: Solid BDC, But ROE Doesn't Justify The NAV Premium

Discover why Hercules Capital (HTGC) is a standout BDC with a tech-driven, high-yield portfolio and solid fundamentals. Click here to read my analysis.

6 days ago - Seeking Alpha

Hercules Capital Closes Upsized Institutional Notes Offering of $350.0 Million 6.000% Unsecured Notes due 2030

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has closed an upsized underwritten public offering of $350.0 million in a...

10 days ago - Business Wire

Hercules Capital Prices Upsized Institutional Notes Offering of $350.0 Million 6.000% Notes due 2030

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has priced an upsized underwritten public offering of $350.0 million in a...

15 days ago - Business Wire

I'm Buying Up To 10% Yields For Recurring Income

I focus on the payback period and high-yield income, highlighting Hercules Capital and VICI Properties for faster capital recoupment and strong recurring income. HTGC stands out with a 10.4% yield, fi...

16 days ago - Seeking Alpha

Fortress Income: 7-11% Yields To Make Money While You Sleep

Buying right and holding tight can be a winning investment strategy over in-vogue short-term strategies. EPD has strong fee-based earnings, strong balance sheet, and growth projects coming online, off...

17 days ago - Seeking Alpha

Buy Any Of 18 Ideal 'Safer' May Dividend Dogs Out Of 70 Graham Value All-Stars (GVAS)

I use YCharts' Value Score and Ben Graham Formula to identify large-cap stocks offering strong value relative to profits, assets, and dividends. Eighteen of twenty-four 'safer' lowest-priced Dividend ...

4 weeks ago - Seeking Alpha

Hercules Capital: Contrarian Buying Opportunity

Hercules Capital's strong Q1 performance and reliable dividends make it a standout for income investors. Learn more about HTGC stock here.

5 weeks ago - Seeking Alpha

Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital

GAITHERSBURG, Md., May 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometa...

6 weeks ago - Benzinga

Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital

GAITHERSBURG, Md., May 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometab...

6 weeks ago - GlobeNewsWire

BDC Weekly Review: Bimodal Q1 Numbers Weigh On The Sector

We take a look at the action in business development companies through the first week of May and highlight some of the key themes we are watching. BDCs fell around 1.5% this week due to a couple of we...

6 weeks ago - Seeking Alpha

Dividend Investors, It's Time To Raise Cash, Here's Why

Despite my usual inclination to invest in dividend-paying stocks, current market valuations and economic risks lead me to prefer raising cash over investing. The 10-year Treasury yield reflects a tug-...

6 weeks ago - Seeking Alpha

2 BDCs On My Recession Radar

BDCs, previously top performers due to high yields and rising rates, now face selling pressure amid economic uncertainty and potential interest rate cuts. Hercules Capital and Trinity Capital, despite...

7 weeks ago - Seeking Alpha

Hercules Capital Announces Date of 2025 Annual Meeting of Stockholders

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), will conduct its 2025 Annual Meeting of Stockholders by virtual meeting on Wednesday, June 18, 20...

7 weeks ago - Business Wire

Hercules capital outlines $270M net debt portfolio growth in Q1 2025 with strong liquidity position

Hercules Capital (HTGC) reports $270M net portfolio growth in Q1 2025, driven by strong originations and $1B+ liquidity.

2 months ago - Seeking Alpha

Hercules Capital, Inc. (HTGC) Q1 2025 Earnings Call Transcript

Hercules Capital, Inc. (NYSE:HTGC) Q1 2025 Earnings Conference Call May 1, 2025 5:00 PM ETCompany ParticipantsMichael Hara - Senior Director, Investor...

2 months ago - Seeking Alpha

Hercules Capital, Inc. 2025 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Hercules Capital, Inc.

2 months ago - Seeking Alpha

Hercules Capital Reports First Quarter 2025 Financial Results

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and establishe...

2 months ago - Business Wire

Hercules Capital declares $0.47 dividend

2 months ago - Seeking Alpha

Hercules Capital Declares a Total Cash Distribution of $0.47 Per Share for the First Quarter 2025

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative venture, growth and established ...

2 months ago - Business Wire